York-based international firm Animalcare Group plc announce that, in line with its geographic expansion strategy, it has acquired a 25% strategic equity stake in InVetro Pty Ltd, an Australian-based “companion animal” health business for A$3m (£1.4m).

“The strategic investment expands Animalcare’s presence in the growing Asia-Pacific veterinary market, building on its acquisition of Randlab completed on 3 January 2025 …” said the York firm.

“InVetro is a development-stage Australian veterinary pharmaceutical company committed to advancing Companion Animal care …

“This minority equity investment offers a capital efficient opportunity for Animalcare to establish a presence in the fast-growing Companion Animal health market in Australia, with potential to access other Asia-Pacific territories over time.

“The Group’s longer-term ambition is to build an overall Companion Animal business in the region with revenues of approximately A$20-25m.”

Animalcare CEO Jenny Winter said: “This strategic investment expands the Group’s geographic footprint in the large and growing Companion Animal health market.

“The Australian market presents a significant opportunity, and this partnership allows us to participate in that growth with a trusted and capable team already on the ground.

“We look forward to supporting the business as it transitions into full-scale commercial operations and begins to maximise its potential.”